These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 9226998

  • 1. Therapeutic advances in amyotrophic lateral sclerosis.
    Louvel E, Hugon J, Doble A.
    Trends Pharmacol Sci; 1997 Jun; 18(6):196-203. PubMed ID: 9226998
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic horizons for amyotrophic lateral sclerosis.
    Rothstein JD.
    Curr Opin Neurobiol; 1996 Oct; 6(5):679-87. PubMed ID: 8937834
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Current pharmacological management of amyotrophic [corrected] lateral sclerosis and a role for rational polypharmacy.
    Weiss MD, Weydt P, Carter GT.
    Expert Opin Pharmacother; 2004 Apr; 5(4):735-46. PubMed ID: 15102560
    [Abstract] [Full Text] [Related]

  • 8. Motor neuron disease: a chemical perspective.
    Wood LK, Langford SJ.
    J Med Chem; 2014 Aug 14; 57(15):6316-31. PubMed ID: 24694032
    [Abstract] [Full Text] [Related]

  • 9. Pharmacologic approaches to the treatment of amyotrophic lateral sclerosis.
    McGeer EG, McGeer PL.
    BioDrugs; 2005 Aug 14; 19(1):31-7. PubMed ID: 15691215
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Amyotrophic lateral sclerosis].
    Moriwaka F.
    Hokkaido Igaku Zasshi; 1997 Jan 14; 72(1):21-5. PubMed ID: 9086359
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of amyotrophic lateral sclerosis--what is the next step?
    Ludolph AC.
    J Neurol; 2000 Dec 14; 247():13-8. PubMed ID: 11200700
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment.
    Goodall EF, Morrison KE.
    Expert Rev Mol Med; 2006 May 24; 8(11):1-22. PubMed ID: 16723044
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amyotrophic lateral sclerosis, excitotoxicity and riluzole.
    Obrenovitch TP.
    Trends Pharmacol Sci; 1998 Jan 24; 19(1):9-11. PubMed ID: 9509893
    [No Abstract] [Full Text] [Related]

  • 20. Clinical and experimental neuroprotection in neurodegenerative diseases is a therapeutic option for the future of amyotrophic lateral sclerosis (ALS). Preface.
    Ludolph AC, Drory VE.
    J Neurol; 2000 Dec 24; 247 Suppl 6():VI/1. PubMed ID: 19714407
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.